lobbying_activities: 1839355
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1839355 | 211be196-01d4-4d8c-89f0-d9db9a52bf70 | Q2 | PHARMAVITE LLC | 286074 | PHARMAVITE LLC | 2016 | second_quarter | FOO | *Adequate FDA resources to implement GMP rules for dietary supplements and to provide adequate funds for full inspection of dietary supplement manufacturers. *Support for prompt publication of NDI Guidance from FDA *Full implementation of DASCA (HR 4771/S2012) *Inclusion of the multivitamin in SNAP legislation in 2018 *Federal solution to gmo labeling issues for food products | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2016-07-11T15:02:27.527000-04:00 |